LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 37.74 | 21.74 | 1788 | 2828 | 0.6322 | 0.8736 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 37.74 | 21.74 | 6 | 2828 | 0.0021 | -0.1675 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 37.74 | 21.74 | 1730 | 2828 | 0.6117 | 0.8648 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 39.71 | 21.74 | 60 | 3084 | 0.0195 | 0.1526 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 39.71 | 21.74 | 1917 | 3084 | 0.6216 | 0.8713 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 39.71 | 21.74 | 16 | 3084 | 0.0052 | -0.0420 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 39.71 | 21.74 | 1825 | 3084 | 0.5917 | 0.8585 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 41.68 | 21.74 | 75 | 3418 | 0.0219 | 0.1850 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 41.68 | 21.74 | 2049 | 3418 | 0.5993 | 0.8645 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 41.68 | 21.74 | 13 | 3418 | 0.0038 | -0.0680 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 41.68 | 21.74 | 1932 | 3418 | 0.5651 | 0.8495 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 43.65 | 21.74 | 78 | 3754 | 0.0208 | 0.1876 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 43.65 | 21.74 | 2156 | 3754 | 0.5743 | 0.8562 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 43.65 | 21.74 | 22 | 3754 | 0.0059 | 0.0016 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 43.65 | 21.74 | 2054 | 3754 | 0.5471 | 0.8441 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 45.62 | 21.74 | 94 | 4150 | 0.0226 | 0.2132 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 45.62 | 21.74 | 2277 | 4150 | 0.5486 | 0.8476 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 45.62 | 21.74 | 15 | 4150 | 0.0036 | -0.0478 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 45.62 | 21.74 | 2145 | 4150 | 0.5168 | 0.8331 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.59 | 21.74 | 94 | 4492 | 0.0209 | 0.2097 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.59 | 21.74 | 2386 | 4492 | 0.5312 | 0.8421 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.59 | 21.74 | 16 | 4492 | 0.0036 | -0.0391 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.59 | 21.74 | 2261 | 4492 | 0.5033 | 0.8292 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 49.56 | 21.74 | 142 | 4838 | 0.0293 | 0.2721 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 49.56 | 21.74 | 2560 | 4838 | 0.5291 | 0.8432 | MN20160310_N01 | J22 |